|
Volumn 26, Issue 5, 1996, Pages 329-333
|
Monitoring neovascularity as an indicator of response to chemotherapy in osteogenic and Ewing sarcoma using magnetic resonance angiography
a a a a a a a |
Author keywords
bone tumor; chemotherapy; Ewing sarcoma; magnetic resonance angiography; magnetic resonance imaging; musculoskeletal neoplasm; osteogenic sarcoma
|
Indexed keywords
ANTINEOPLASTIC AGENT;
GADOLINIUM PENTETATE;
GADOLINIUM PENTETATE MEGLUMINE;
ADOLESCENT;
ARTICLE;
CANCER CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL FEATURE;
EWING SARCOMA;
HISTOLOGY;
HUMAN;
HUMAN TISSUE;
INTRAVENOUS DRUG ADMINISTRATION;
LIMB SALVAGE;
MAGNETIC RESONANCE ANGIOGRAPHY;
NEOVASCULARIZATION (PATHOLOGY);
NUCLEAR MAGNETIC RESONANCE IMAGING;
OSTEOSARCOMA;
PATIENT MONITORING;
PRIORITY JOURNAL;
PROGNOSIS;
TUMOR VASCULARIZATION;
ADOLESCENT;
ANTINEOPLASTIC AGENTS;
BONE NEOPLASMS;
DOUBLE-BLIND METHOD;
FEMALE;
GADOLINIUM DTPA;
HUMANS;
MAGNETIC RESONANCE ANGIOGRAPHY;
MAGNETIC RESONANCE IMAGING;
MALE;
NEOVASCULARIZATION, PHYSIOLOGIC;
ORGANOMETALLIC COMPOUNDS;
OSTEOSARCOMA;
PENTETIC ACID;
SARCOMA, EWING'S;
|
EID: 0029968302
PISSN: 00981532
EISSN: None
Source Type: Journal
DOI: 10.1002/(SICI)1096-911X(199605)26:5<329::AID-MPO5>3.0.CO;2-K Document Type: Article |
Times cited : (20)
|
References (10)
|